Paris, France

Jens Duebel

This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: National Institute of Health and Medical Research, Sorbonne Université, Centre National De La Recherche Scientifique. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jens Duebel. Retrieved from https://idiyas.com/inventor/jens-duebel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jens Duebel - Innovative Inventor from Paris

Introduction: Jens Duebel is a renowned inventor based in Paris, France, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Jens Duebel holds several patents in the areas of renewable energy, artificial intelligence, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Jens Duebel has worked with leading research institutions and multinational companies, consistently pushing the boundaries of innovation and creating solutions to complex challenges.

Collaborations: Due to his collaborative nature, Jens Duebel has partnered with top universities and research centers worldwide, fostering a culture of innovation and knowledge exchange.

Conclusion: Jens Duebel's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the global technological landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…